Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Brindisi
Clinical trial register · Italy

Clinical Trials in Brindisi, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6788 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:19 UTC
6788
Studies in scope
all four open statuses
4077
Recruiting now
open to new participants
1016
Lead sponsors
across recruiting studies
Top sites
Milan 2855 Bologna 1282 Roma 1266 Naples 983 Rome 968
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
European Institute of Oncology3 Gruppo Italiano Malattie EMatologiche dell'Adulto3 IRCCS Eugenio Medea3 IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy2 Eli Lilly and Company2 Agios Pharmaceuticals, Inc.2 Biotronik SE & Co. KG2 Associazione Italiana Ematologia Oncologia Pediatrica1 Istituto Giannina Gaslini1 Genmab1 Fondazione Michelangelo1 Daiichi Sankyo1 IRCCS Fondazione Stella Maris1 Celgene1 ETOP IBCSG Partners Foundation1 Azienda USL Reggio Emilia - IRCCS1 MedSIR1 Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS1 Janssen-Cilag Ltd.1 CSL Behring1 Priothera SAS1 Federation of Italian Cooperative Oncology Groups1 Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 Consorzio Oncotech1 MediWound Ltd1 Show all 39
Site location
Milan2855 Bologna1282 Roma1266 Naples983 Rome968 Florence788 Pavia573 Brescia523 Padova504 Genova490 Rozzano473 Bari451 Pisa401 Bergamo378 Meldola355 Catania340 Ancona298 Monza281 Verona281 Palermo277 Torino275 Modena259 Aviano201 Messina167 Alessandria164 Show all 490
All 490 locations
Target enrolment
to

Trials with a site in Brindisi

49 of 6788 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Chiesi Farmaceutici S.p.A.
Phase 3
700
Brescia, Brindisi, Genoa, Messina, Milan, Naples, Parma, Pisa
2026-11-16
Recruiting
BIO|STREAM.CSP CLS
NCT07608822Sinus Node Disease, Atrioventricular Block
Biotronik SE & Co. KG
Observational
150
Brindisi, Milan, Novara, Piove di Sacco, Roma, Taranto
2026-05-29
Recruiting
BIO|STREAM.CSP Study
NCT07393009Cardiac Pacing, Cardiac Pacemaker, Implantable Cardioverter Defibrillator, Cardiac Resynchronization Therapy Devices
Biotronik SE & Co. KG
Observational
1,000
Bergamo, Brindisi, Milan, Novara, Piove di Sacco, Roma, Taranto
2026-05-25
Active, closed
CSL Behring
Phase 2
84
Brindisi, Milan, Modena, Monza, Naples, Verona
2026-01-22
Active, closed
Appropriate Management of Hepatic EncePhalopaThy AmonG cirrhOtic patieNts Admitted to Internal Medicine
NCT07727070Cirrhoses, Liver, Portal Hypertension Related to Cirrhosis, Liver Stiffness, Hepatic Encephalopathy
Fadoi Foundation, Italy
Observational
400
Ariccia, Arzignano, Assisi, Bologna, Bolzano, Brindisi, Casale Monferrato, Catanzaro
2025-12-05
Recruiting
European Institute of Oncology
Observational
750
Bergamo, Brescia, Brindisi, Crema, Lecco, Legnano, Milan, Modena
2025-09-29
Recruiting
European Institute of Oncology
Observational
1,000
Ancona, Aviano, Bagno a Ripoli, Bari, Bergamo, Brescia, Brindisi, Busto Arsizio
2025-06-25
Recruiting
MediWound Ltd
Phase 3
216
Brindisi, Naples, Genoa, Pisa, Padova, Roma
2025-06-01
Recruiting
European Institute of Oncology
Phase 2
45
Monza, Roma, Brindisi, Milan
2025-03-06
Recruiting
Istituto Clinico Humanitas
Observational
300
Benevento, Bergamo, Brindisi, Brescia, Campobasso, Florence, Genova, Messina
2025-02-25
Active, closed
Genmab
Phase 3
584
Brindisi, Milan, Ponderano, Roma, Torino
2025-02-07
Recruiting
A Composite Assay for HER2-positive Early-stage Breast Cancer Management
NCT06762977Breast Cancer Early Stage Breast Cancer (Stage 1-3), HER2
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
180
Brindisi, Naples
2024-11-13
Recruiting
Sustained Endogenous Attention Deficits in Attention Deficit Hyperactivity Disorder
NCT06900400ADHD - Attention Deficit Disorder With Hyperactivity
IRCCS Eugenio Medea
Not applicable
50
Brindisi, Lecce
2024-11-11
Recruiting
Real World Pediatric Oncology Rehabilitation in Italy ( ReWori )
NCT07368582Pediatric Cancer, Pediatric Cancer Patients, Pediatric Oncology, Rehabilitation
Associazione Italiana Ematologia Oncologia Pediatrica
Observational
249
Bergamo, Bologna, Bolzano, Bosisio Parini, Brindisi, Catania, Conegliano, Florence
2024-07-19
Recruiting
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
NCT06459024Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Observational
4,000
Bologna, Brindisi, Brescia, Cuneo, Como, Cremona, Ferrara, Genova
2024-06-28
Recruiting
Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors
NCT05934084Classical Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL)
Fondazione Italiana Linfomi - ETS
Not applicable
552
Ancona, Aviano, Bari, Belluno, Barletta, Bolzano, Brescia, Brindisi
2024-02-26
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Alessandria, Bologna, Brindisi, Catania, Genova, Legnano, Milan, Pavia
2024-01-22
Recruiting
Janssen-Cilag Ltd.
Observational
900
Bologna, Bolzano, Brindisi, Florence, Lecce, Milan, Naples, Palermo
2023-12-18
Active, closed
Hoffmann-La Roche
Phase 3
1,050
Brindisi, Avellino, Naples, Bologna, Meldola, Parma, Aviano (PN), Udine
2023-12-11
Recruiting
Azienda USL Reggio Emilia - IRCCS
Observational
3,000
Brindisi, Milan, Reggio Emilia, Trento
2023-11-23
Active, closed
AstraZeneca
Observational
151
Alessandria, Ancona, Bari, Barletta, Brindisi, Campobasso, Catania, Catanzaro
2023-08-08
Recruiting
IRCCS Fondazione Stella Maris
Observational
300
Brindisi, Milan, Calambrone
2023-06-01
Recruiting
IRCCS Eugenio Medea
Observational
40
Brindisi, Bosisio Parini, Conegliano
2023-01-19
Recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
1,000
Aviano, Ancona, Avellino, Brindisi, Catania, Genova, Mantua, Meldola
2022-12-03
Active, closed
Eli Lilly and Company
Phase 3
8,000
Ancona, Bergamo, Bologna, Brindisi, Candiolo, Florence, Genova, Milan
2022-10-04
Recruiting
Istituto Giannina Gaslini
Observational
400
Ancona, Bari, Bergamo, Bologna, Bolzano, Brescia, Brindisi, Cagliari
2022-10-01
Recruiting
Priothera SAS
Phase 3
366
Reggio Calabria, San Giovanni Rotondo, Alessandria, Ascoli Piceno, Brindisi, Florence, Lecce, Milan
2022-06-16
Active, closed
A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT)
NCT04770753Non-Transfusion-dependent Alpha-Thalassemia, Non-Transfusion-dependent Beta-Thalassemia
DrugMitapivat
Agios Pharmaceuticals, Inc.
Phase 3
194
Brindisi, Cagliari, Ferrara, Genova, Milan, Modena, Naples, Orbassano
2021-12-20
Active, closed
Novartis Pharmaceuticals
Phase 3
1,007
Brindisi, Foggia, Pozzilli, Messina, Modena, Pavia, Orbassano, Naples
2021-12-13
Active, closed
Agios Pharmaceuticals, Inc.
Phase 3
258
Brindisi, Cagliari, Ferrara, Genova, Milan, Modena, Naples, Orbassano
2021-11-30
Recruiting
Study on the Diagnosis and Management of CLL in Italy by GIMEMA
NCT04867915Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, MBL-CLL - Monoclonal B-Cell Lymphocytosis Chronic Lymphocytic Leukaemia-Type
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
12,500
Alessandria, Brescia, Brindisi, Candiolo, Florence, Messina, Mestre, Milan
2021-10-13
Active, closed
University of Campania Luigi Vanvitelli
Phase 2
219
Ancona, Acquaviva delle Fonti, Bari, Castellana Grotte, Benevento, Brindisi, Monserrato, Catania
2021-07-15
Active, closed
GlaxoSmithKline
Phase 3
40
Ancona, Bologna, Brindisi, Candiolo to, Catania, Genova, Meldola FC, Milan
2021-06-28
Active, closed
Daiichi Sankyo
Phase 3
1,600
Catania, Milan, Ancona, Aviano, Bari, Belluno, Bologna, Brindisi
2020-12-04
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 3
274
Alessandria, Ancona, Ascoli Piceno, Bari, Bologna, Brescia, Brindisi, Castelfranco Veneto
2020-11-27
Active, closed
Consorzio Oncotech
Observational
600
Aviano, Bari, Bergamo, Brindisi, Chieti, Como, Cuneo, Florence
2019-10-24
Active, closed
ETOP IBCSG Partners Foundation
Phase 3
405
Aviano, Bergamo, Brindisi, Meldola, Milan, Novara, Parma, Pavia
2019-08-27
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
NCT04064060Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
DrugLuspatercept
Celgene
Phase 3
665
Florence, Allessandria, Bologna, Brindisi, Cagliari, Ferrara, Genoa, Lecce
2019-08-12
Recruiting
Use of EBPT in Critically Ill Patients With AKI and/or Multiorgan Failure
NCT04033224Critical Illness, Acute Kidney Injury, Sepsis, Systemic Inflammatory Response Syndrome
Careggi Hospital
Observational
1,000
Empoli, Lido di Camaiore, Rozzano, San Donato Milanese, Monza, Brindisi, Florence, Pavia
2019-07-16
Recruiting
Protocol ITANET - Registry
NCT04282083Gastro-entero Pancreatic Neuroendocrine Tumors
Italian Association Neuroendocrine Tumors
Observational
3,600
Rozzano, Peschiera del Garda, Ancona, Bari, Bologna, Bolzano, Brescia, Brindisi
2019-05-25
Active, closed
National Register of Actionable Mutations
NCT05918666Solid Tumours in Advanced Stages
Federation of Italian Cooperative Oncology Groups
Observational
2,098
Ancona, Arezzo, Avellino, Aviano, Bari, Bergamo, Brindisi, Catania
2018-10-27
Active, closed
Fondazione Michelangelo
Phase 3
650
Bergamo, Brindisi, Faenza, Genova, Meldola, Milan, Modena, Negrar
2018-09-07
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
530
Ancona, Bologna, Brindisi, Cagliari, Catania, Catanzaro, Cona, Cosenza
2017-11-13
Recruiting
Registry for Patients With X-Linked Hypophosphatemia
NCT03193476X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd
Observational
1,489
Bari, Benevento, Bologna, Brindisi, Cagliari, Florence, Genova, Latina
2017-09-12
Active, closed
MedSIR
Phase 2
377
Bologna, Brindisi, Cremona, Mantua, Milan, Monza, Piacenza
2017-06-26
Active, closed
Eli Lilly and Company
Phase 3
493
Brindisi, Cona, Genoa, Candiolo, Prato, Negrar, Bergamo, Bologna
2014-11-06
Active, closed
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Phase 3
1,000
Casale Monferrato, Fabriano, Avellino, Bari, Bergamo, Treviglio, Benevento, Brindisi
2013-06
Recruiting
PREgnancy and FERtility Registry
NCT02895165Breast Neoplasms, Pregnancy, Fertility Preservation
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Observational
1,000
Asti, Brindisi, Monserrato, Cuneo, Cona, Genoa, Lecce, Lido di Camaiore
2012-11
Recruiting
Virtual Reality for Pediatric Motor Rehabilitation.
NCT06449495Coordination and Balance Disturbances
IRCCS Eugenio Medea
Not applicable
50
Bosisio Parini, Conegliano, Brindisi
2012-09-01
Rows per page Showing 1–49 of 49
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-italy/city/brindisi

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,788 studies in total at the last sync on 13 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 49 of those studies with a site in Brindisi.

How many clinical trials are recruiting in Brindisi?

27 of the 49 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 21 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Brindisi), 49 studies
PhaseStudiesRecruitingShare
Observational241949%
Phase 318436.7%
Phase 2418.2%
Not applicable336.1%

Most active sponsors

Lead sponsors with the most studies (Brindisi)
Lead sponsorStudiesRecruiting
European Institute of Oncology33
Gruppo Italiano Malattie EMatologiche dell'Adulto32
IRCCS Eugenio Medea33
Agios Pharmaceuticals, Inc.20
Biotronik SE & Co. KG22
Eli Lilly and Company20
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy21
Associazione Italiana Ematologia Oncologia Pediatrica11
AstraZeneca10
Azienda USL Reggio Emilia - IRCCS11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.